MS Therapies

Links shared publicly online about this topic

MS Therapy Gilenya (Fingolimod) Updated Prescribing Data In USA

medicalnewstoday.com — “Novartis says it has updated prescribing data for multiple sclerosis therapy Gilenya (Fingolimod) after a review by the Food and Drug Administration (FDA). The prescribing information incluView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 20, 2012 at 4:05 pm By:

mnt_drugapprov MNT Drug Approvals Health News

MS Therapy Gilenya (Fingolimod) Updated Prescribing Data In USA http://t.co/wfddGJkc #regulatory

1 month ago...

Pivotal Meeting Probes MS Therapy Use in Children : National MS Society

nationalmssociety.org — “MS stops people from moving. The National MS Society exists to make sure it doesn't.View full resource at nationalmssociety.org

  • View Related
  • Share

Most Recently Shared on February 13, 2012 at 8:29 pm By:

mssociety National MS Society Support

News! Pivotal Meeting Probes MS Therapy Use in Children http://t.co/2t0B6yOJ

3 months ago...

National MS Society Blog: Choosing and staying on MS therapy: What are people doing and why?

blog.nationalmssociety.org — “Julie Stachowiak, PhD Writer, ms.about.com Everyone has their own journey with multiple sclerosis (MS). One part of life with MS involves tr...View full resource at blog.nationalmssociety.org

  • View Related
  • Share

Most Recently Shared on October 21, 2011 at 2:45 pm By:

mssociety National MS Society Support

Choosing and staying on #MS therapy: What are people doing and why? http://t.co/iUpR1PCa #ECTRIMS

7 months ago...

Complementary Therapies and MS: Aromatherapy, Music Therapy, Art Therapy - Alternative Treatment - Multiple Sclerosis

healthcentral.com — “The value of complementary therapy is impressive when added to any traditional or alternative therapy. These therapies and more like them undoubtedly add fun to daily life, enhance personal quality of life, and make life worth living.View full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on December 6, 2011 at 6:30 pm By:

healthcentral HealthCentral Health Site

There are many different complementary therapies available to improve quality of life for those living with MS: http://t.co/pB5Gcljt

6 months ago...

Multiple Sclerosis (MS) Alternative Therapies : Learning Center on Healthline.com

healthline.com — “For additional information, see multiple sclerosis resources.View full resource at healthline.com

  • View Related
  • Share

Most Recently Shared on December 6, 2010 at 9:17 am By:

MSclerosisLine Health Line Health Site

Check out these alternative therapy techniques for the treatment of Multiple Sclerosis. http://sns.ly/ShO77

1 year ago...

AAN 2011: Oral Cladribine Reduces Relapses in MS Patients Who Failed Injectable Therapies

hcplive.com — “Results from the CLARITY study show cladribine reduces the relapse rate in multiple sclerosis patients who have failed other disease-modifying therapies.View full resource at hcplive.com

  • View Related
  • Share

Most Recently Shared on April 14, 2011 at 2:01 pm By:

HCPLive_Neuro HCPLive Neurology

#AAN2011 CLARITY study shows #cladribine reduces relapse rate in injection-intolerant #multiplesclerosis patients http://hcp.lv/dPBXxT

1 year ago...

New Study Is The First North American Clinical Trial To Test Adult Mesenchymal Stem Cell Transplantation As A New Therapy For MS

medicalnewstoday.com — “A team of researchers at three landmark Cleveland institutions have come together to launch a new clinical trial of an experimental treatment for multiple sclerosis (MS). Researchers at the ClevelView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on August 26, 2011 at 8:05 am By:

mnt_clinical MNT Clinical Trials Health News

New Study Is The First North American Clinical Trial To Test Adult Mesenchymal Stem Cell Transplantation As A New Ther... http://mnt.to/3Zck

9 months ago...

New research may lead to therapy that delays onset, reduces severity of MS symptoms

physorg.com — “People suffering from multiple sclerosis may benefit if patent-pending research conducted at Purdue University shows that a decades-old drug approved by the FDA to treat hypertension also can delay the onset and reduce the severity of MS symptoms.View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on March 15, 2011 at 6:30 pm By:

HBP_Wisdom High Blood Pressure OW Health

New research may lead to therapy that delays onset, reduces severity of MS symptoms: People suffering from multi... http://bit.ly/h1gqw0

1 year ago...

Study: MS Drugs Help, But Come at High Cost -- American Academy of Neurology

aan.com — “A new study examining the cost-effectiveness of drugs to treat multiple sclerosis (MS) in the United States finds that the health gains from these drugs come at a very high cost compared to basic therapy to control the symptoms of MS and compared to treatments for other chronic diseases. The research is published in the July 20, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology . Disease-modifying drugs for MS became available in the 1990s. While theView full resource at aan.com

  • View Related
  • Share

Most Recently Shared on July 20, 2011 at 8:36 pm By:

Multiple Sclerosis and You - Multiple Sclerosis (MS) Symptoms, Diagnosis and Treatments

ms.about.com — “Multiple sclerosis (MS) information and insight from an expert who also has multiple sclerosis. What you need to know about multiple sclerosis symptoms, treatment, relapses/exacerbations, causes, research and alternative/complementary therapies. We also have a community forum for discussion, newsletter and more.View full resource at ms.about.com

  • View Related
  • Share

Most Recently Shared on July 24, 2009 at 10:43 pm By:

MS_Focus MSF Support

Have you checked out ms.about.com by Julie Stachowiak, Ph.D. @msguide. Lots of good information! http://t.co/heC9r2x

3 years ago...

From the Front Lines: MS Research to Follow in 2012 - Yahoo! News

news.yahoo.com — “From Yahoo! News: National MS Society Live Webcast December 13 Will Offer MS News You Can Use From Internationally Renowned ResearchersNew York, NY (PRWEB) December 08, 2011 This year saw exciting research progress in efforts to stop multiple sclerosis, restore function that’s been lost and end the disease entirely. At least three emerging therapies are advancing through the pipeline toward FDA review while at least four clinical trials focusing on progressive MS continue to move forward. ...View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on December 8, 2011 at 6:32 pm By:

Urology_Wisdom Urology & Nephrology OW Health

From the Front Lines: MS Research to Follow in 2012: National MS Society Live Webcast December 13 Will Offer MS ... http://t.co/djKi2Zz0

6 months ago...

FDA Approves Breakthrough Pill to Treat (MS) - Patient Power

patientpower.info — “The first-ever oral therapy to treat relapsing-remitting multiple sclerosis has been approved by the FDA. University of Washington neurologist and MS specialist, Dr. Sylvia Lucas, explains what it means and gives guidance for patients.View full resource at patientpower.info

  • View Related
  • Share

Most Recently Shared on September 24, 2010 at 8:14 pm By:

UWMedicineNews UW Medicine News Hospital

Want to know more about pill approved by FDA to treat MS? UW's Dr. Sylvia Lucas talks @patientpower http://ow.ly/2Jzoo #multiplesclerosis

2 years ago...

Medicine and Technology [part of HCPLive]: FDA approves Gilenya capsules (fingolimod) for multiple sclerosis (MS)

medicineandtechnology.com — “Medicine and Technology [part of HCPLive]: FDA approves Gilenya capsules (fingolimod) for multiple sclerosis (MS)View full resource at medicineandtechnology.com

  • View Related
  • Share

Most Recently Shared on September 22, 2010 at 9:18 pm By:

DrJosephKim Joseph Kim, MD, MPH Doctor and Physician

FDA approves Gilenya capsules (fingolimod) for multiple sclerosis (MS) http://goo.gl/fb/1Ck0t

2 years ago...

Higher Patient Adherence To Disease Modifying Therapies Reduced Costs For MS Patients

medicalnewstoday.com — “Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found thaView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 29, 2011 at 8:05 am By:

mnt_multiplescl MNT Multiple Scl Health News

Higher Patient Adherence To Disease Modifying Therapies Reduced Costs For MS Patients http://t.co/Sy1DzZBL #multiplesclerosis

6 months ago...

Combination therapy in multiple sclerosis : The Lancet Neurology

thelancet.com — “Combination therapy in multiple sclerosis. By - Devon Conway MD, Jeffrey A Cohen MDView full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on February 26, 2010 at 12:23 am By:

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390